Transdermal delivery of 40-nm silk fibroin nanoparticles.


Journal

Colloids and surfaces. B, Biointerfaces
ISSN: 1873-4367
Titre abrégé: Colloids Surf B Biointerfaces
Pays: Netherlands
ID NLM: 9315133

Informations de publication

Date de publication:
01 Mar 2019
Historique:
received: 19 04 2018
revised: 06 11 2018
accepted: 06 12 2018
pubmed: 24 12 2018
medline: 1 6 2019
entrez: 23 12 2018
Statut: ppublish

Résumé

Transdermal administration of drugs improves their bioavailability and is capable of systemic and local treatment. To improve the skin permeability of drugs, nano-sized systems have attracted attention as drug carriers for transdermal drug delivery system. We considered that silk fibroin composed of a crystalline region with many hydrophobic amino acids and an amorphous region with many hydrophilic amino acids was useful as a carrier for transdermal administration of a drug because of the balance between hydrophilicity and hydrophobicity. In this study, silk fibroin nanoparticles with mean volume diameters of 42.3 nm were successfully prepared, and storage stability was confirmed by storing the nanoparticle suspension at 4, 32, and 37 °C for a week. At any storage temperature, the mean volume diameter and standard deviation were stable. The polydispersity indexes were 0.19-0.23, and no specific trends were observed. Then, to investigate the transdermal delivery route of the silk fibroin nanoparticles, skin permeability in vivo was evaluated using mice. Six hours after administration, fluorescent substances were observed in the dermis in addition to the stratum corneum, hair follicles and the epidermis around them. This result indicated that fibroin nanoparticles with the mean volume diameter of 40-nm penetrated the stratum corneum and was delivered deep into the skin. Therefore, it was suggested that small nanoparticles prepared using silk fibroin are useful for drug delivery to the dermis.

Identifiants

pubmed: 30579057
pii: S0927-7765(18)30894-4
doi: 10.1016/j.colsurfb.2018.12.012
pii:
doi:

Substances chimiques

Cross-Linking Reagents 0
Drug Carriers 0
Fluorescent Dyes 0
Rhodamines 0
Succinimides 0
N-hydroxysuccinimide suberic acid ester 68528-80-3
Fibroins 9007-76-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

564-568

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Issei Takeuchi (I)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda, Chiba 278-8510, Japan; Center for Drug Delivery Research, Tokyo University of Science, 2641, Yamazaki, Noda, Chiba 278-8510, Japan.

Yosuke Shimamura (Y)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda, Chiba 278-8510, Japan.

Yuki Kakami (Y)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda, Chiba 278-8510, Japan.

Tsunenori Kameda (T)

Silk Materials Research Unit, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization (NARO), 2-1-2, Kannondai, Tsukuba, Ibaraki 305-8602, Japan.

Keitaro Hattori (K)

Kowa Research Laboratories for Advanced Science, Kowa Company Ltd., 1-25-5, Kannondai, Tsukuba, Ibaraki 305-0856, Japan.

Seiji Miura (S)

DDS Research Dept. Fuji Research Laboratories, Kowa Company Ltd., 332-1, Onoshinden, Fuji, Shizuoka 417-8650, Japan.

Hiroyuki Shirai (H)

DDS Research Dept. Fuji Research Laboratories, Kowa Company Ltd., 332-1, Onoshinden, Fuji, Shizuoka 417-8650, Japan.

Mutsuo Okumura (M)

Member of the Board Pharmaceutical Research Dept. Kowa Company Ltd., 6-29, Nishiki 3-chome, Naka-ku, Nagoya, Aichi 460-8625, Japan.

Toshio Inagi (T)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda, Chiba 278-8510, Japan.

Hiroshi Terada (H)

Niigata University of Pharmacy and Applied Life Sciences, 265-1, Higashijima, Akiha-ku, Niigata City, Niigata 956-8603, Japan.

Kimiko Makino (K)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda, Chiba 278-8510, Japan; Center for Drug Delivery Research, Tokyo University of Science, 2641, Yamazaki, Noda, Chiba 278-8510, Japan. Electronic address: makino@rs.noda.tus.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH